10 Best Growth Stocks to Buy With Highest Upside Potential

​8. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Number of Hedge Fund Holders:132

Analyst Upside Potential: 39.90%

​Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the Best Growth Stocks to Buy With Highest Upside Potential. Wall Street has a positive view on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) as 71% of the 28 analysts covering the stock have a Buy rating. Moreover, the 12-month median price target of the Street reflects more than 36.9% upside from the current level.

​On April 1, Barclays analyst Eliana Merle maintained a Buy rating on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) with a price target of $527. The rating comes after the company presented clinical data on its cardiovascular portfolio at the American College of Cardiology’s Annual Scientific Session. At the conference, the company shared HELIOS-B study results for Vutrisiran, its ATTR-CM therapy.

​Management noted that analyses covered quality-of-life gains, subgroup efficacy, and real-world adherence over 613.8 days, where 93.8% of patients stayed on treatment. In a post hoc analysis, 8.0% of Vutrisiran patients progressed to advanced disease versus 10.7% on placebo during the double-blind phase.

​That said, the company posted strong gains in fiscal Q4 2025 results. It posted a revenue of $1.10 billion, up 84.95% year-over-year. The EPS for the quarter came in at $0.82.

​Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is a biopharmaceutical company that develops and commercializes novel therapeutics based on ribonucleic acid interference.